These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17821905)

  • 1. [The drug treatment for hyperlipidemic patient with diabetes mellitus--pharmacology based medicine and pathogenesis based medicine].
    Inoue I
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():386-406. PubMed ID: 17821905
    [No Abstract]   [Full Text] [Related]  

  • 2. [To give or not to give? Towards the indication of CSE inhibitors ("statins")].
    Teichert M; Lüer AK; Stichtenoth DO
    Med Monatsschr Pharm; 2008 May; 31(5):184-5. PubMed ID: 18552075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus and hyperlipidemia].
    Uchida N; Shuto Y; Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():733-7. PubMed ID: 11347163
    [No Abstract]   [Full Text] [Related]  

  • 4. Statin therapy for the treatment of diabetic dyslipidemia.
    Haffner SM
    Diabetes Metab Res Rev; 2003; 19(4):280-7. PubMed ID: 12879405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing hyperlipidaemia.
    Wang TW
    Practitioner; 2004 Sep; 248(1662):660, 662-8. PubMed ID: 15376551
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins and renal function in patients with diabetes mellitus.
    Athyros VG; Papageorgiou AA; Elisaf M; Mikhailidis DP;
    Curr Med Res Opin; 2003; 19(7):615-7. PubMed ID: 14606984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E; Sarcinella R
    Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T
    Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemorheological aspects of hyperlipidemia].
    Elishkewitch K; Shapira I; Berliner S
    Harefuah; 2001 May; 140(5):435-6. PubMed ID: 11419070
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ongoing clinical trials by vascular statin, cerivastatin].
    Tomita N; Morishita R; Ogihara T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():477-82. PubMed ID: 11347117
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerivastatin.
    Cheng-Lai A
    Heart Dis; 2000; 2(1):93-9. PubMed ID: 11728245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 14. Interview: role of managed care in implementing NCEP-ATP III guidelines.
    Carver JC
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():7. PubMed ID: 12608153
    [No Abstract]   [Full Text] [Related]  

  • 15. Should angiotensin II receptor blockers and statins be combined?
    Nickenig G
    Circulation; 2004 Aug; 110(8):1013-20. PubMed ID: 15326080
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hyperlipidemia in primary practise in Germany: sub-group analyses from the 4E-registry with particular emphasis on men and women with diabetes mellitus.
    Assmann G; Schulte H; Cullen P; Neiss A; Bestehorn K
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):85-91. PubMed ID: 17318766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surprising effects of statins.
    Roberts SS
    Diabetes Forecast; 2004 Nov; 57(11):45-6. PubMed ID: 15510377
    [No Abstract]   [Full Text] [Related]  

  • 19. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies to reduce complications of type 2 diabetes.
    Ullom-Minnich P
    J Fam Pract; 2004 May; 53(5):366-75. PubMed ID: 15125821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.